Drugs / trivalent oral poliovirus vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02189811 Comparator | Sep 2014 → Apr 2016 | poliomyelitis | Aga Khan University | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | trivalent oral poliovirus vaccine | “one dose of trivalent oral poliovirus vaccine (tOPV)” PMID 29477307 ↗ Feb 2018 |
| Known as | tOPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02189811 ↗ |
| Modality | Vaccine | “one dose of trivalent oral poliovirus vaccine (tOPV)” PMID 29477307 ↗ Feb 2018 |
| Route | Oral | “trivalent oral poliovirus vaccine (tOPV)” PMID 29477307 ↗ Feb 2018 |